FERDOUS Tarannum Ferdous Tarannum

Researcher Number	70647932
Other IDs
Affiliation (based on the past Project Information) *help	2024: 山口大学, 医学部, 特別医学研究員 2015 – 2018: 山口大学, 医学部附属病院, 学術研究員 2016: 山口大学, 大学院医学系研究科, 学術研究員 2013 – 2014: 山口大学, 医学(系)研究科(研究院), 学術研究員
Review Section/Research Field	Principal Investigator Surgical dentistry / Basic Section 57060:Surgical dentistry-related Except Principal Investigator Surgical dentistry
Keywords	Principal Investigator アポトーシス / 口腔扁平上皮癌 / PD -1/PD-L1 / gut bacteria / oral microbiomes / 抗癌剤 / 抗PD-1抗体 / 免疫チェックポイント阻害剤 / 併用療法 / Cetuximab … More / シスプラチン / マウスPD-1抗体 / Cetuximab耐性 / Cisplatin耐性 / 5-FU耐性 / PD-1抗体 / drud resistance / cetuximab / cisplatin / 5-FU / PD-1 / 効果予測因子 / 口腔癌 / RTP3 / 耐性 / ドセタキセル / 耐性因子 / Docetaxel / oral cancer / predictive factor / resistance / docetaxel … More Except Principal Investigator 癌幹細胞 / 口腔癌 / 子宮頸癌細胞 / 乳癌細胞 / 肝癌細胞 / リプログラム因子 / リプログラミングファクター / マイクロアレイ / Sulfasalazine / CD44v / 人工癌幹細胞 / スルファサラジン / IPA / エピソーマルベクター / iPS / リプログラミング / タンパク質修飾 / プロテオーム / 腫瘍診断学 / 腫瘍生物学 / 悪性腫瘍 / 口腔扁平上皮癌 / 機能解析 / calreticulin / プロテオミクス / 足場依存性喪失 / Calreticulin Less

Detection of novel therapeutic targets and biomarkers via identification of beneficial oral/ gut bacteria to enhance the response of PD1/PD-L1 blockade therapy in oral cancer patientsPrincipal Investigator
- Principal Investigator
  
  Ferdous Tarannum
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 57060:Surgical dentistry-related
- Research Institution
  Yamaguchi University
Development of the combined therapy with an immune check point inhibitor against anticancer agent-resistant oral squamous cell carcinoma cellsPrincipal Investigator
- Principal Investigator
  
  Ferdous Tarannum
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Surgical dentistry
- Research Institution
  Yamaguchi University
Development of new predictive factors for malignant alteration of oral cancer by the functional analysis of the factors in regard to loss of anchorage dependence.
- Principal Investigator
  
  TAKENAWA Takanori
- Project Period (FY)
  2015 – 2016
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Surgical dentistry
- Research Institution
  Yamaguchi University
Development of the new therapeutic strategy for recurrence/metastatic oral cancer -toward natural life with oral cancer-
- Principal Investigator
  
  UEYAMA Yoshiya
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Surgical dentistry
- Research Institution
  Yamaguchi University
Identification of new predictive factor for combined chemotherapy with docetaxel against oral cancerPrincipal Investigator
- Principal Investigator
  
  FERDOUS Tarannum
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Surgical dentistry
- Research Institution
  Yamaguchi University

All 2019 2018 2017 2016 2015 2014 Other

All Journal Article Presentation

[Journal Article] Prognostic significance of FOXM1 in oral squamous cell carcinoma patients treated by docetaxel-containing regimens.2019
- Author(s)
  Koji Harada, Tarannum Ferdous, Haruyasu Minami and Katsuaki Mishima
- Journal Title
  
  Mol Clin Oncol.
  
  Volume: 10 Pages: 29-36
- DOI
  10.3892/mco.2018.1770
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K09814, KAKENHI-PROJECT-18H03001, KAKENHI-PROJECT-16K20581
[Journal Article] The Elental elemental diet for against chemoradiotherapy-induced oral mucositis: a prospective study in patients with oral squamous cell carcinoma.2019
- Author(s)
  Koji Harada, Haruyasu Minami, Tarannum Ferdous, Yoshiaki Kato, Hirotsugu Umeda, Daiju Horinaga, Kenichiro Uchida, Sung Chul Park, Hideki Hanazawa, Shotaro Takahashi, Misaki Ohota, Hiromi Matsumoto, Junko Maruta, Hiromi Kakutani, Sanae Aritomi, Keiko Shibuya, Katsuaki Mishima
- Journal Title
  
  Mol Clin Oncol.
  
  Volume: 10 Pages: 159-167
- DOI
  10.3892/mco.2018.1769
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K09814, KAKENHI-PROJECT-18H03001, KAKENHI-PROJECT-16K20581
[Journal Article] PD-L1 expression in malignant salivary gland tumors.2018
- Author(s)
  Koji Harada, Tarannum Ferdous, Yoshiya Ueyama
- Journal Title
  
  BMC Cancer
  
  Volume: 18 Issue: 1 Pages: 156-156
- DOI
  10.1186/s12885-018-4069-3
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K20581, KAKENHI-PROJECT-15K11292, KAKENHI-PROJECT-18K09814
[Journal Article] Low carbonyl reductase 1 expression is associated with poor prognosis in patients with oral squamous cell carcinoma2018
- Author(s)
  Ryota Yamanouchi, Koji Harada, Tarannum Ferdous, Yoshiya Ueyama
- Journal Title
  
  Mol Clin Oncol.
  
  Volume: 8 Pages: 400-406
- DOI
  10.3892/mco.2018.1548
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K20581, KAKENHI-PROJECT-15K11292, KAKENHI-PROJECT-18K09814
[Journal Article] Elemental diet inhibits pro-inflammatory cytokine production in keratinocytes through the suppression of NFκB activation.2018
- Author(s)
  Koji Harada, Tarannum Ferdous, Yoichi Mizukami, Katsuaki Mishima
- Journal Title
  
  Oncology reports
  
  Volume: in press Pages: 361-368
- DOI
  10.3892/or.2018.6440
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15K11292, KAKENHI-PROJECT-18K09814, KAKENHI-PROJECT-18K11128, KAKENHI-PROJECT-18H03001, KAKENHI-PROJECT-15K08210, KAKENHI-PROJECT-16K20581
[Journal Article] Calreticulin is a novel independent prognostic factor for oral squamous cell carcinoma.2017
- Author(s)
  Koji Harada, Takanori Takenawa, Tarannum Ferdous, Yasuhiro Kuramitsu, Yoshiya Ueyama
- Journal Title
  
  Oncology Letters
  
  Volume: 13 Issue: 6 Pages: 4857-4862
- DOI
  10.3892/ol.2017.6062
- Peer Reviewed / Acknowledgement Compliant / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K20534, KAKENHI-PROJECT-15K11292, KAKENHI-PROJECT-17K07218
[Journal Article] Gimeracil enhances the antitumor effect of cisplatin against oral squamous cell carcinoma cells in vitro and in vivo2016
- Author(s)
  Koji Harada, Tarannum Ferdous, Toyoko Harada, Takanori Takenawa, Yoshiya Ueyama
- Journal Title
  
  Oncology Letters
  
  Volume: in press
- Peer Reviewed / Acknowledgement Compliant / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K20534
[Journal Article] Induction of artificial cancer stem cells from tongue cancer cells by defined reprogramming factors.2016
- Author(s)
  Harada K, Ferdous T, Cui D, Kuramitsu Y, Matsumoto T, Ikeda E, Okano H, Ueyama Y.
- Journal Title
  
  BMC Cancer
  
  Volume: 16 Issue: 1 Pages: 548-548
- DOI
  10.1186/s12885-016-2416-9
- Peer Reviewed / Acknowledgement Compliant / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26463045, KAKENHI-PROJECT-15K11292, KAKENHI-PROJECT-16K20581
[Journal Article] METFORMIN IN COMBINATION WITH 5-FLUOROURACIL SUPPRESSES TUMOR GROWTH BY INHIBITING WARBURG EFFECT IN HUMAN ORAL SQUAMOUS CELL CARCINOMA2016
- Author(s)
  Koji Harada, Tarannum Ferdous, Toyoko Harada, Yoshiya Ueyama
- Journal Title
  
  International Journal of Oncology
  
  Volume: in press
- Peer Reviewed / Acknowledgement Compliant / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26463045
[Journal Article] Gimeracil Exerts Radiosensitizing Effects on Oral Squamous Cell Carcinoma Cells In Vitro and In Vivo.2016
- Author(s)
  Harada K, Ferdous T, Ueyama Y.
- Journal Title
  
  Anticancer Res
  
  Volume: 36 Issue: 11 Pages: 5923-5930
- DOI
  10.21873/anticanres.11179
- Peer Reviewed / Acknowledgement Compliant / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K11292, KAKENHI-PROJECT-16K20581
[Journal Article] High Expression of Stathmin1 is a Strong Prognostic Marker in Oral Squamous Cell Carcinoma Patients Treated by Docetaxel-containing Regimens.2015
- Author(s)
  Koji Harada, Tarannum Ferdous, Toyoko Harada, Yoshiya Ueyama
- Journal Title
  
  Clin Exp Med
  
  Volume: - Issue: 1 Pages: 1-6
- DOI
  10.1007/s10238-015-0403-0
- Peer Reviewed / Acknowledgement Compliant / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26463045, KAKENHI-PROJECT-25861948, KAKENHI-PROJECT-16K20581
[Journal Article] Osteogenic cell fractions isolated from mouse tongue muscle2015
- Author(s)
  Harada K, Harada T, Ferdous T, Takenawa T. and Ueyama Y.
- Journal Title
  
  Mol. Med. Rep.
  
  Volume: - Issue: 1 Pages: 31-36
- DOI
  10.3892/mmr.2015.3350
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23227005, KAKENHI-PROJECT-24593034, KAKENHI-PROJECT-25861948, KAKENHI-PROJECT-25861949, KAKENHI-PROJECT-26463045, KAKENHI-PROJECT-15K11292
[Journal Article] High expression of stathmin 1 is a strong prognostic marker in oral squamous cell carcinoma patients treated by docetaxel-containing regimens.2015
- Author(s)
  Koji Harada, Tarannum Ferdous, Toyoko Harada, Yoshiya Ueyama
- Journal Title
  
  Clin Exp Med.
  
  Volume: - Pages: 1-6
- Peer Reviewed / Acknowledgement Compliant / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25861949
[Journal Article] Paclitaxel in combination with cetuximab exerts antitumor effect by suppressing NF-κB activity in human oral squamous cell carcinoma cell lines2014
- Author(s)
  Harada K, Kobayashi H, Ferdous T, Ueyama Y.
- Journal Title
  
  International Journal of Oncology
  
  Volume: 45 Issue: 6 Pages: 2439-2445
- DOI
  10.3892/ijo.2014.2655
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24593034, KAKENHI-PROJECT-25861949
[Journal Article] Establishment of 5-fluorouracil-resistant oral squamous cell carcinoma cell lines with epithelial-to-mesenchymal transition changes2014
- Author(s)
  KOJI HARADA, TARANNUM FERDOUS and YOSHIYA UEYAMA
- Journal Title
  
  INTERNATIONAL JOURNAL OF ONCOLOGY
  
  Volume: 44 Issue: 4 Pages: 1302-1308
- DOI
  10.3892/ijo.2014.2270
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24593034, KAKENHI-PROJECT-25861949
[Presentation] Expression of EpCAM in human oral squamous cell carcinoma2018
- Author(s)
  Koji Harada, Rieko Fujiwara, Tarannum Ferdous, Hirotsugu Umeda, Daijyu Horinaga, Kenichiro Uchida and Katsuaki Mishima
- Organizer
  ACOMS 2018
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K20581
[Presentation] Elemental diet Elental against chemoradiotherapy-induced oral mucositis: a prospective study in patients with oral squamous cell carcinoma2018
- Author(s)
  Koji Harada, Tarannum Ferdous, Yoshiaki Kato, Hirotsugu Umeda, Daiju Horinaga, Kenichiro Uchida, SungChul Park, Hideki Hanazawa, Shotaro Takahashi, Misaki Ohota, Hiromi Matsumoto, Junko Maruta, Hiromi Kakutani, Keiko Shibuya, Katsuaki Mishima
- Organizer
  日本癌治療学会2018
- Data Source
  KAKENHI-PROJECT-16K20581
[Presentation] Induction of artificial cancer stem cells from oral cancer cells by defined reprogramming factors.2016
- Author(s)
  Yoshiya Ueyama, Koji Harada, Tarannum Ferdous
- Organizer
  Oral, Mouth and Throat Cancer
- Place of Presentation
  Sheraton Portland Airport Hotel, Portland, (USA)
- Year and Date
  2016-08-15
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26463045
[Presentation] Expression of calreticulin is a novel independent prognostic factor for oral squamous cell carcinoma2016
- Author(s)
  Takanori Takenawa, Koji Harada, Tarannum Ferdous, Yoshiya Ueyama
- Organizer
  ESMO 2016
- Place of Presentation
  The Bella Center, Copenhagen (Denmark)
- Year and Date
  2016-10-07
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K20534
[Presentation] High Expression of FOXM1 is a Strong Prognostic Marker in Oral Squamous Cell Carcinoma.2016
- Author(s)
  Tarannum Ferdous, Koji Harada, Yoshiya Ueyama
- Organizer
  ESMO 2016
- Place of Presentation
  The Bella Center (Copenhagen, Denmark)
- Year and Date
  2016-10-07
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K20581
[Presentation] Expression of calreticulin is a novel independent prognostic factor for oral squamous cell carcinoma.2016
- Author(s)
  Takanori Takenawa, Koji Harada, Tarannum Ferdous, Yoshiya Ueyama
- Organizer
  ESMO 2016
- Place of Presentation
  The Bella Center (Copenhagen, Denmark)
- Year and Date
  2016-10-07
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K20581
[Presentation] Metformin in combination with 5-fluorouracil suppresses tumor growth by inhibiting Warburg effect in human oral squamous cell carcinoma cells2015
- Author(s)
  Tarannum Ferdous, Koji Harada, Yoshiya Ueyama
- Organizer
  International Symposium of the cancer research center of Lyon (CRCL)
- Place of Presentation
  CENTRE DE LYON, Lyon, France.
- Year and Date
  2015-09-21
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25861949
[Presentation] リプログラミング因子導入による癌細胞の脱分化2014
- Author(s)
  原田耕志、Ferdous T, 上山吉哉
- Organizer
  日本口腔科学会　中国四国地方会
- Place of Presentation
  徳島大学歯学部大講義室（徳島）
- Year and Date
  2014-10-25
- Data Source
  KAKENHI-PROJECT-26463045
[Presentation] Identification of docetaxel-resistance related genes in oral squamous cell carcinoma
- Author(s)
  Ferdous T, Harada K, Ueyama Y.
- Organizer
  AAOMS
- Place of Presentation
  Hawai USA
- Year and Date
  2014-09-08 – 2014-09-13
- Data Source
  KAKENHI-PROJECT-25861949
[Presentation] Establishment of Induced Cancer Stem Cells by Transfection of a Tongue Cancer Cell Line with Yamanaka‘s Factor.
- Author(s)
  Harada K, Ferdous T, Harada T, Ueyama Y.
- Organizer
  EACMFS 2014
- Place of Presentation
  プラハ　チェコ
- Year and Date
  2014-09-23 – 2014-09-26
- Data Source
  KAKENHI-PROJECT-26463045
[Presentation] Establishment of Induced Cancer Stem Cells by Transfection of a Tongue Cancer Cell Line with Yamanaka‘s Factor
- Author(s)
  Harada K, Harada T, Ferdous T, Ueyama Y.
- Organizer
  EACMFS 2014
- Place of Presentation
  Praque, Czech Republic
- Year and Date
  2014-09-23 – 2014-09-26
- Data Source
  KAKENHI-PROJECT-25861949

1. HARADA Koji (60253217)

# of Collaborated Projects: 4 results

# of Collaborated Products: 21 results
2. TAKENAWA Takanori (30711270)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
3. KURAMITSU Yasuhiro (50281811)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. UEYAMA Yoshiya (00168668)

# of Collaborated Projects: 1 results

# of Collaborated Products: 6 results
5. HISANO Takahiro

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. FUJIWARA Rieko

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
7. 蔵満保宏

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
8. 竹縄忠臣

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

FERDOUS Tarannum Ferdous Tarannum

Research Projects

Research Products

Co-Researchers

Detection of novel therapeutic targets and biomarkers via identification of beneficial oral/ gut bacteria to enhance the response of PD1/PD-L1 blockade therapy in oral cancer patientsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of the combined therapy with an immune check point inhibitor against anticancer agent-resistant oral squamous cell carcinoma cellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of new predictive factors for malignant alteration of oral cancer by the functional analysis of the factors in regard to loss of anchorage dependence.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of the new therapeutic strategy for recurrence/metastatic oral cancer -toward natural life with oral cancer-

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Identification of new predictive factor for combined chemotherapy with docetaxel against oral cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Prognostic significance of FOXM1 in oral squamous cell carcinoma patients treated by docetaxel-containing regimens.2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The Elental elemental diet for against chemoradiotherapy-induced oral mucositis: a prospective study in patients with oral squamous cell carcinoma.2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] PD-L1 expression in malignant salivary gland tumors.2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Low carbonyl reductase 1 expression is associated with poor prognosis in patients with oral squamous cell carcinoma2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Elemental diet inhibits pro-inflammatory cytokine production in keratinocytes through the suppression of NFκB activation.2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Calreticulin is a novel independent prognostic factor for oral squamous cell carcinoma.2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Gimeracil enhances the antitumor effect of cisplatin against oral squamous cell carcinoma cells in vitro and in vivo2016

Author(s)

Journal Title

Data Source

[Journal Article] Induction of artificial cancer stem cells from tongue cancer cells by defined reprogramming factors.2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] METFORMIN IN COMBINATION WITH 5-FLUOROURACIL SUPPRESSES TUMOR GROWTH BY INHIBITING WARBURG EFFECT IN HUMAN ORAL SQUAMOUS CELL CARCINOMA2016

Author(s)

Journal Title

Data Source

[Journal Article] Gimeracil Exerts Radiosensitizing Effects on Oral Squamous Cell Carcinoma Cells In Vitro and In Vivo.2016

Author(s)

Journal Title